The high degree of concordance between the two imaging platforms after linear calibration was confirmed by the analysis of a second non-overlapping tissue microarray cohort (Cohort 2) independently stained for pYStat5, representing tumors from 382 estrogen receptor-positive breast cancer patients (Supplementary Figure 1). Here, ESR1 is linked to breast cancer.